{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:06Z","timestamp":1790035206713,"version":"4.0.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Education, Science, and Culture, Japan","award":["25293283"],"award-info":[{"award-number":["25293283"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["16H05416"],"award-info":[{"award-number":["16H05416"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["25293323"],"award-info":[{"award-number":["25293323"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["25462333"],"award-info":[{"award-number":["25462333"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["16K10862"],"award-info":[{"award-number":["16K10862"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["15K10446"],"award-info":[{"award-number":["15K10446"]}]},{"name":"The Ministry of Education, Science, and Culture, Japan","award":["16K10596"],"award-info":[{"award-number":["16K10596"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Soft tissue sarcoma (STS) is a rare cancer that develops from soft tissues in any part of the body. Despite major advances in the treatment of STS, patients are often refractory to conventional radiotherapy, leading to poor prognosis. Enhancement of sensitivity to radiotherapy would therefore improve the clinical outcome of STS patients. We previously revealed that the tumor-specific, replication-competent oncolytic adenovirus OBP-301 kills human sarcoma cells. In this study, we investigated the radiosensitizing effect of OBP-301 in human STS cells. The\n                    <jats:italic>in vitro<\/jats:italic>\n                    antitumor effect of OBP-301 and ionizing radiation in monotherapy or combination therapy was assessed using highly radiosensitive (RD-ES and SK-ES-1) and moderately radiosensitive (HT1080 and NMS-2) STS cell lines. The expression of markers for apoptosis and DNA damage were evaluated in STS cells after treatment. The therapeutic potential of combination therapy was further analyzed using SK-ES-1 and HT1080 cells in subcutaneous xenograft tumor models. The combination of OBP-301 and ionizing radiation showed a synergistic antitumor effect in all human STS cell lines tested, including those that show different radiosensitivity. OBP-301 was found to enhance irradiation-induced apoptosis and DNA damage via suppression of anti-apoptotic myeloid cell leukemia 1 (MCL1), which was expressed at higher levels in moderately radiosensitive cell lines. The combination of OBP-301 and ionizing radiation showed a more profound antitumor effect compared to monotherapy in SK-ES-1 (highly radiosensitive) and HT1080 (moderately radiosensitive) subcutaneous xenograft tumors. OBP-301 is a promising antitumor reagent to improve the therapeutic potential of radiotherapy by increasing radiation-induced apoptosis in STS.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0250643","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T15:42:11Z","timestamp":1619106131000},"page":"e0250643","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED: Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression"],"prefix":"10.1371","volume":"16","author":[{"given":"Toshinori","family":"Omori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-1050","authenticated-orcid":true,"given":"Hiroshi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Hasei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Sugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Komatsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4790-933X","authenticated-orcid":true,"given":"Aki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-850X","authenticated-orcid":true,"given":"Toshiyuki","family":"Kunisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-6051","authenticated-orcid":true,"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"issue":"5","key":"pone.0250643.ref001","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin."},{"issue":"8","key":"pone.0250643.ref002","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1200\/JCO.2006.09.8525","article-title":"Evidence-based recommendations for local therapy for soft tissue sarcomas","volume":"25","author":"PW Pisters","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0250643.ref003","first-page":"200","article-title":"Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine","volume":"70","author":"AC Gamboa","year":"2020","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"pone.0250643.ref004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"AC Begg","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pone.0250643.ref005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5435\/00124635-200901000-00006","article-title":"Soft-tissue sarcoma","volume":"17","author":"NF Gilbert","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"pone.0250643.ref006","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"AM Davis","year":"2005","journal-title":"Radiother Oncol"},{"issue":"16","key":"pone.0250643.ref007","doi-asserted-by":"crossref","first-page":"27428","DOI":"10.18632\/oncotarget.16194","article-title":"Development of a radiosensitivity gene signature for patients with soft tissue sarcoma","volume":"8","author":"Z Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"pone.0250643.ref008","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clon.2009.07.016","article-title":"Pathology of soft tissue sarcomas","volume":"21","author":"K Thway","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"3","key":"pone.0250643.ref009","first-page":"305","article-title":"Gamma-H2AX\u2014a novel biomarker for DNA double-strand breaks","volume":"22","author":"LJ Kuo","year":"2008","journal-title":"In Vivo"},{"issue":"19","key":"pone.0250643.ref010","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/0008-5472.CAN-04-1433","article-title":"Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines","volume":"64","author":"JP Banath","year":"2004","journal-title":"Cancer Res"},{"issue":"7283","key":"pone.0250643.ref011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"R Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"1 Pt 1","key":"pone.0250643.ref012","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1078-0432.CCR-1075-3","article-title":"Telomerase-specific replication-selective virotherapy for human cancer","volume":"10","author":"T Kawashima","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0250643.ref013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1349-7006.2007.00665.x","article-title":"Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus","volume":"99","author":"Y Hashimoto","year":"2008","journal-title":"Cancer Sci"},{"issue":"7","key":"pone.0250643.ref014","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-10-2066","article-title":"Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas","volume":"17","author":"T Sasaki","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"22","key":"pone.0250643.ref015","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-10-2333","article-title":"Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery","volume":"70","author":"S Kuroda","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0250643.ref016","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1158\/1535-7163.MCT-08-0901","article-title":"Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer","volume":"8","author":"D Liu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"pone.0250643.ref017","doi-asserted-by":"crossref","first-page":"28953","DOI":"10.1038\/srep28953","article-title":"Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas","volume":"6","author":"S Osaki","year":"2016","journal-title":"Sci Rep."},{"issue":"9","key":"pone.0250643.ref018","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/cas.13316","article-title":"Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction","volume":"108","author":"Y Yamakawa","year":"2017","journal-title":"Cancer Sci"},{"issue":"2","key":"pone.0250643.ref019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","article-title":"A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors","volume":"18","author":"J Nemunaitis","year":"2010","journal-title":"Mol Ther"},{"issue":"5","key":"pone.0250643.ref020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004280050271","article-title":"Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1","volume":"433","author":"S Imaizumi","year":"1998","journal-title":"Virchows Archiv-an International Journal of Pathology"},{"issue":"3","key":"pone.0250643.ref021","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"4","key":"pone.0250643.ref022","first-page":"2697","article-title":"Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death","volume":"25","author":"H Skvara","year":"2005","journal-title":"Anticancer Res"},{"issue":"3","key":"pone.0250643.ref023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4161\/cbt.4.3.1496","article-title":"Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells","volume":"4","author":"L Song","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"pone.0250643.ref024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tranon.2014.12.004","article-title":"Targeting mcl-1 for radiosensitization of pancreatic cancers","volume":"8","author":"D Wei","year":"2015","journal-title":"Transl Oncol."},{"issue":"12","key":"pone.0250643.ref025","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1158\/1078-0432.CCR-03-0774","article-title":"Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of Mcl-1 antisense Oligonucleotides with low-dose cyclophosphamide","volume":"10","author":"C Thallinger","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"16","key":"pone.0250643.ref026","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1158\/0008-5472.CAN-04-3664","article-title":"Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1","volume":"65","author":"T Wirth","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0250643.ref027","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3892\/or.2012.1636","article-title":"Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus","volume":"27","author":"L You","year":"2012","journal-title":"Oncol Rep"},{"issue":"23","key":"pone.0250643.ref028","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1101\/gad.1156903","article-title":"DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells","volume":"17","author":"A Cuconati","year":"2003","journal-title":"Genes Dev"},{"issue":"4","key":"pone.0250643.ref029","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0092-8674(90)90112-R","article-title":"Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation.","volume":"62","author":"S Bagchi","year":"1990","journal-title":"Cell"},{"issue":"9","key":"pone.0250643.ref030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.onc.1205157","article-title":"Direct repression of the Mcl-1 promoter by E2F1","volume":"21","author":"R Croxton","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"pone.0250643.ref031","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/abbi.2002.2761","article-title":"Identification of novel E2F1-regulated genes by microarray","volume":"399","author":"Y Ma","year":"2002","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"pone.0250643.ref032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2012.10.033","article-title":"MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy","volume":"329","author":"JX Zhang","year":"2013","journal-title":"Cancer Lett"},{"issue":"3","key":"pone.0250643.ref033","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695010","article-title":"Tumor suppressor miR-29c regulates radioresistance in lung cancer cells","volume":"39","author":"E Arechaga-Ocampo","year":"2017","journal-title":"Tumour Biol"},{"issue":"7","key":"pone.0250643.ref034","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10495-013-0841-7","article-title":"Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1","volume":"18","author":"JE Kwon","year":"2013","journal-title":"Apoptosis"},{"key":"pone.0250643.ref035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2017.00153","article-title":"Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization","volume":"7","author":"SM O\u2019Cathail","year":"2017","journal-title":"Front Oncol."},{"issue":"14","key":"pone.0250643.ref036","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4161\/cc.9.14.12354","article-title":"MCL-1 localizes to sites of DNA damage and regulates DNA damage response","volume":"9","author":"S Jamil","year":"2010","journal-title":"Cell Cycle"},{"issue":"3","key":"pone.0250643.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00535-16","article-title":"MCL-1 Depletion Impairs DNA Double-Strand Break Repair and Reinitiation of Stalled DNA Replication Forks","volume":"37","author":"AR Mattoo","year":"2017","journal-title":"Mol Cell Biol"},{"issue":"3","key":"pone.0250643.ref038","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2013.06.002","article-title":"Clinical perspectives of cancer stem cell research in radiation oncology","volume":"108","author":"R Butof","year":"2013","journal-title":"Radiother Oncol"},{"issue":"6","key":"pone.0250643.ref039","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2012.940","article-title":"Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines","volume":"4","author":"WD Liu","year":"2012","journal-title":"Oncol Lett"},{"issue":"2","key":"pone.0250643.ref040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3892\/or.2013.2486","article-title":"CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics","volume":"30","author":"BH Feng","year":"2013","journal-title":"Oncol Rep"},{"issue":"7120","key":"pone.0250643.ref041","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"S Bao","year":"2006","journal-title":"Nature"},{"issue":"2","key":"pone.0250643.ref042","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2011.10.012","article-title":"CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma","volume":"315","author":"LS Piao","year":"2012","journal-title":"Cancer Lett"},{"issue":"3","key":"pone.0250643.ref043","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.radonc.2013.10.040","article-title":"CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells","volume":"110","author":"A Desai","year":"2014","journal-title":"Radiother Oncol"},{"issue":"23","key":"pone.0250643.ref044","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1158\/1078-0432.CCR-13-0742","article-title":"A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S\/G2\/M phases","volume":"19","author":"S Yano","year":"2013","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0343958","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}},{"DOI":"10.1371\/journal.pone.0343958","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"record-id":"73124"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:27:56Z","timestamp":1772666876000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250643"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0250643","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}